Author: Dr. Neil Fawkes, MBChB, DPM, FFPM — Chief Medical Officer, AmiLyfe Bioscience, LLC
Published: 2026-10-9 | Last Reviewed: 2026-10-6
Quick Answer
Asking the right questions before cancer treatment begins is one of the most effective ways a patient can prepare for what lies ahead. The pre-treatment period offers a limited but valuable window to understand what GI side effects to expect, how they will be managed, what nutritional and hydration strategies are appropriate for the specific treatment planned, and what supportive care resources are available. Patients who enter treatment with this knowledge are better positioned to manage symptoms proactively, maintain hydration and nutritional status, communicate effectively with their care team. This preparation also supports informed decisions about supportive care tools such as enterade®, a glucose-free, amino acid-based medical food formulated for the dietary management of gastrointestinal dysfunction associated with cancer therapy, to be used under medical supervision.
Introduction: Prepared Patients Have Better Outcomes
The relationship between a patient and their oncology care team is most effective when it is built on clear, two-way communication. Oncologists, oncology nurses, and registered dietitians are equipped to answer detailed questions about treatment-related side effects and supportive care strategies. While oncology care teams are trained to address these topics, patients who come prepared with specific questions open the door to more detailed, personalized conversations, and the earlier those conversations happen, the better positioned patients are to get ahead of symptoms before they develop.
Research in oncology consistently shows that patients who actively participate in their care, ask informed questions, understand what to expect, and know when to seek help, experience better symptom management, fewer unplanned hospitalizations, and greater overall satisfaction with their treatment. The pre-treatment period, before symptoms develop and before the demands of active treatment are in full force, is the ideal time to have these conversations.
The questions below are organized by topic area and are intended to support productive pre-treatment conversations with oncologists, oncology nurses, registered dietitians, and other members of the oncology care team. Not every question applies to every patient or treatment plan, but having a prepared list of questions helps ensure that the most important topics are covered before treatment begins.
Questions to Ask About GI Side Effects
Understanding which GI side effects are most likely with the planned treatment, how severe they may be, and how they will be managed is foundational to effective pre-treatment preparation.
What GI side effects should I expect with my specific treatment regimen? Different chemotherapy agents, radiation fields, and immunotherapy regimens have different GI side-effect profiles. Asking specifically about the most likely GI complications of the planned treatment, including their typical onset, duration, and severity, helps patients prepare appropriately and avoid being caught off guard.
How severe are GI side effects likely to be, and what factors affect this? Individual risk factors, including prior GI conditions, age, hydration status, and nutritional status at the start of treatment, can influence the severity of treatment-related GI symptoms. Understanding personal risk level helps calibrate preparation strategies.
What is the grading scale for GI symptoms, and when should I contact the care team? The National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) provides a standardized grading system for GI symptoms. Patients who understand the difference between Grade 1 symptoms that are manageable at home and Grade 3 or 4 symptoms that require medical intervention are better equipped to respond appropriately when symptoms develop.
Will my treatment cause both acute and delayed GI symptoms? Some cancer treatment regimens can cause GI symptoms primarily in the first 24 hours, while others produce delayed symptoms that peak days later. Knowing which pattern to expect helps patients and caregivers plan for the most symptomatic periods.
Are there any signs or symptoms that should prompt an emergency department visit rather than a call to the nurse line? The threshold between a nurse line call and an emergency department visit is not always obvious and can vary based on treatment type and individual risk factors. Ask your care team before treatment begins to clearly define which symptoms require immediate emergency care versus routine after-hours contact and keep that information somewhere accessible at home.
Questions to Ask About Nausea and Vomiting Management
Will I be prescribed antiemetic medications, and if so when should I take them? Not all cancer treatments carry the same risk of nausea and vomiting, and antiemetic medications are prescribed based on how likely a specific regimen is to cause those symptoms. Ask whether antiemetic medications are part of your treatment plan, when to take them, and whether you should continue them during the days after treatment when delayed nausea can develop.
What should I do if my prescribed antiemetics are not adequately controlling nausea? Breakthrough nausea despite prescribed antiemetics is common. Knowing in advance what the escalation plan is — whether that means calling the nurse line, taking a rescue medication, or coming in for evaluation — prevents delays in appropriate management.
Are there any non-medication strategies that complement antiemetic treatment? Dietary modifications, acupressure, ginger supplementation, and environmental adjustments can complement prescribed antiemetics. Specialized medical foods such as enterade®, formulated for the dietary management of gastrointestinal dysfunction associated with cancer therapy, may also be worth discussing with your care team as part of a broader nausea and GI symptom management strategy. Asking about these before treatment begins allows patients to implement them from the first cycle rather than discovering them reactively.
Will my treatment cause anticipatory nausea, and if so, how is that managed differently? Anticipatory nausea, a conditioned response that develops after poorly controlled treatment-related nausea and vomiting, requires different management than treatment-induced nausea. Patients who are aware of this distinction can alert the care team early if conditioned nausea responses begin to develop.
Questions to Ask About Diarrhea Management
How likely is my treatment to cause diarrhea, and what type of diarrhea should I expect? Different treatments cause diarrhea through different mechanisms, and the management approach depends on the type. Chemotherapy, radiation, and immunotherapy can each affect the GI tract differently, and some treatments carry a higher risk of severe or prolonged diarrhea than others. Ask your care team specifically about the diarrhea risk associated with your regimen, when it is most likely to occur, and what signs would indicate that it is becoming serious enough to require medical attention.
What antidiarrheal medications are appropriate for my treatment, and when should I use them? Not all antidiarrheal medications are appropriate for all treatment-related diarrhea. Loperamide is commonly used for non-immune-mediated chemotherapy-induced diarrhea but is not appropriate for immune-mediated colitis. Knowing which medications are recommended and which should be avoided before symptoms develop prevents inappropriate self-management.
What dietary modifications should I follow if diarrhea develops? A low-fiber, low-fat, low-residue diet is the standard approach during active treatment-related diarrhea, but specific recommendations may vary based on the treatment received and the patient's baseline GI status. Getting personalized dietary guidance from an oncology dietitian before treatment begins means patients have a plan in place before symptoms develop.
Are there hydration products specifically recommended for managing diarrhea-related fluid and electrolyte losses? Standard sports drinks and high-sugar beverages are not optimally formulated for the hydration needs of patients with treatment-related GI dysfunction. Asking specifically about oncology-appropriate hydration options, including glucose-free medical foods such as enterade®, a sugar-free amino acid-based medical food formulated for the dietary management of GI dysfunction associated with cancer therapy, allows patients to have appropriate products available before symptoms begin rather than scrambling to find them during an acute episode.
Questions to Ask About Nutrition
Should I see an oncology registered dietitian before treatment begins? Pre-treatment nutritional assessment is one of the most evidence-supported interventions in oncology supportive care. Patients who do not receive an automatic dietitian referral should ask specifically for one before treatment starts. A pre-treatment assessment establishes a baseline, identifies nutritional risk, and allows for personalized preparation.
What are my protein and caloric needs during treatment, and how do they differ from normal recommendations? Oncology nutrition guidelines recommend elevated protein intake during treatment, typically 1.2 to 1.5 grams per kilogram of body weight per day (approximately 0.5 to 0.7 grams per pound), significantly higher than standard recommendations. Understanding elevated nutritional targets before treatment begins helps patients prepare to meet them.
Are there foods or supplements I should avoid during treatment? Some foods can interact with certain chemotherapy agents, and some supplements can interfere with treatment efficacy or affect laboratory monitoring. Getting personalized guidance on dietary restrictions and supplement use before treatment begins prevents inadvertent interference with the treatment plan.
What oral nutritional supplements, if any, are appropriate for my situation? For patients who anticipate difficulty maintaining adequate intake during treatment, discussing appropriate oral nutritional supplementation options before treatment begins allows for informed preparation. The composition of supplements matters — high-sugar formulations may be less appropriate for patients at risk of treatment-related diarrhea.
What is the plan if I am losing significant weight during treatment? Understanding in advance what the threshold is for escalating nutritional support during treatment, and what options are available if oral intake becomes insufficient, helps patients and caregivers recognize and respond to nutritional decline early rather than waiting until it has significantly progressed.
Questions to Ask About Hydration
How much fluid should I be drinking each day, and does this change on treatment days? Hydration requirements during cancer treatment are elevated, and they may be significantly higher on treatment days, particularly for patients receiving nephrotoxic chemotherapy agents that require pre- and post-infusion hydration protocols. Understanding personalized fluid targets before treatment begins supports consistent hydration habits.
What types of fluids are most appropriate for maintaining hydration during treatment? Plain water, sports drinks, and specialized oncology hydration products have different compositions and serve different roles in managing hydration during treatment-related GI distress. Getting specific guidance on appropriate fluid choices before treatment begins allows patients to make informed hydration decisions from the start of the first cycle.
What are the warning signs of dehydration I should watch for at home? Early signs of dehydration, including dark urine, reduced urine output, dizziness, and dry mouth, can be managed at home if recognized early. Severe signs, including rapid heartbeat, confusion, and inability to keep fluids down, require prompt medical attention. Understanding this distinction before treatment begins improves timely recognition and response.
Is enterade® appropriate for my situation, and when should I start using it? enterade® is a glucose-free, amino acid-based medical food formulated for the dietary management of gastrointestinal dysfunction associated with cancer therapy. Its formulation uses sodium-amino acid co-transport pathways to support fluid and electrolyte absorption during periods of intestinal stress. Some patients benefit from introducing it before treatment begins so that it is already part of their routine when GI symptoms develop. Discussing its use with the oncology team before treatment starts ensures that it is used appropriately and at the right time. enterade® is available without a prescription through major retailers, including Amazon.
Questions to Ask About Supportive Care Resources
What supportive care resources are available through this cancer center? Many cancer centers offer oncology social work services, nutrition counseling, patient navigation, palliative care consultation, integrative medicine services, and mental health support. Patients who know what resources are available before treatment begins are more likely to access them proactively.
Is there an oncology nurse navigator I can contact between appointments? Nurse navigators serve as the primary point of contact for patients managing symptoms between clinical appointments. Establishing this contact before the first treatment cycle ensures that patients know who to call when symptoms develop.
What is the best way to reach the care team if symptoms develop between appointments? Most oncology practices have a nurse line for after-hours symptom management. Knowing the correct number to call, what information to have ready, and what symptoms warrant an immediate call versus a scheduled message prevents delays in appropriate care.
Are there patient education materials or online resources that complement what we have discussed? Written or digital patient education materials allow patients and caregivers to review key information between appointments. Asking for these before treatment begins extends the impact of pre-treatment conversations.
Questions to Ask About the Recovery Period
What GI symptoms should I expect after treatment ends, and how long do they typically last? Many patients are surprised to find that GI symptoms persist or even temporarily worsen in the weeks after treatment ends. Understanding what is normal during the post-treatment period and what warrants medical attention helps patients navigate recovery with appropriate expectations.
Will I need ongoing dietitian support after treatment ends? Post-treatment nutrition has distinct challenges, including weight restoration, muscle mass recovery, dietary reintroduction, and gut microbiome rebalancing. Asking about continued engagement with the dietitian before treatment ends prevents a gap in nutritional support during the recovery period.
When can I expect my appetite and bowel habits to return to normal? Recovery timelines vary based on treatment type, duration, and individual patient factors. Getting a realistic estimate of the recovery trajectory before treatment begins helps patients and caregivers set appropriate expectations and recognize when recovery is not progressing as expected.
Key Takeaways
Asking informed questions before cancer treatment begins is one of the most effective ways a patient can prepare for the treatment experience ahead. The pre-treatment period offers a unique window to understand what to expect, establish a plan for managing symptoms, connect with supportive care resources, and make informed decisions about nutrition, hydration, and GI management strategies before they are urgently needed.
The most productive pre-treatment conversations cover GI side effect expectations and grading, antiemetic and antidiarrheal management plans, nutrition and hydration targets and strategies, supportive care resources and contact information, and recovery expectations. Patients who enter treatment with this knowledge are better equipped to manage symptoms proactively, maintain their treatment schedule, and protect their quality of life throughout the treatment course.
Oncology-appropriate tools such as enterade®, formulated for the dietary management of gastrointestinal dysfunction associated with cancer therapy, are most beneficial when introduced as part of a planned supportive care strategy discussed with the oncology team before treatment begins, rather than discovered reactively during an acute GI episode.
Sources and References
1. Arends, J., et al. "ESPEN guidelines on nutrition in cancer patients." Clinical Nutrition vol. 36,1 (2017): 11-48. https://doi.org/10.1016/j.clnu.2016.07.015
2. Chauhan, A., et al. (2021). Can an amino acid mixture alleviate gastrointestinal symptoms in neuroendocrine tumor patients? BMC Cancer, 21(1), 580. https://doi.org/10.1186/s12885-021-08315-4
3. De Filipp, Z., et al. (2021). Randomized study of enterade® to reduce diarrhea in patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Asian Pacific Journal of Cancer Prevention, 22(1), 301-304. https://doi.org/10.31557/APJCP.2021.22.1.301
4. Hesketh, P. J., et al. "Antiemetics: ASCO Guideline Update." Journal of Clinical Oncology vol. 38,24 (2020): 2782-2797. https://doi.org/10.1200/JCO.20.01296
5. Luque, L., et al. (2020). Alleviation of cancer therapy-induced gastrointestinal toxicity using an amino acid medical food. Food and Nutrition Journal, 5, 216. https://doi.org/10.29011/2575-7091.100116
6. Mitchell, L. F., et al. (2023). JL1115C: Evaluating the use of an amino acid food to alleviate chemotherapy-induced toxicity in cancer patients [Poster]. ASCO Annual Meeting. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11308534/
7. National Cancer Institute, Division of Cancer Therapy and Diagnosis. Common Terminology Criteria for Adverse Events (CTCAE) Version 6.0. U.S. Department of Health and Human Services. https://dctd.cancer.gov/research/ctep-trials/for-sites/adverse-events/ctcae-v6.pdf
8. PDQ Supportive and Palliative Care Editorial Board. (2024). Nutrition in cancer care (PDQ): Health professional version. National Cancer Institute. https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq
9. Ravasco, P. "Nutrition in Cancer Patients." Journal of Clinical Medicine vol. 8,8 (2019): 1211. https://doi.org/10.3390/jcm8081211
10. Yin, L., et al. (2014). An amino acid mixture mitigates radiation-induced gastrointestinal toxicity. Health Physics, 106(6), 734-744. https://doi.org/10.1097/HP.0000000000000117
enterade® 2026. All rights reserved. This content is provided for informational and educational purposes only and does not constitute medical advice. Patients should consult their oncology care team before making any changes to their treatment plan or nutritional regimen.